跳至主要内容
临床试验/ISRCTN17421871
ISRCTN17421871已完成未知

Advancing Survivorship after Cancer: Outcomes Trial

niversity College London Joint Research Office0 个研究点目标入组 1,348 人开始时间: 2015年7月29日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
1,348

研究概览

简要总结

2016 Protocol article in https://www.ncbi.nlm.nih.gov/pubmed/27881518 protocol

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • Current inclusion criteria as of 18/12/2020:
  • ASCOT patient survey:
  • All individuals diagnosed with breast, prostate or colorectal cancer in 2012-2015 at an NHS trust in London or Essex.
  • ASCOT pilot trial:
  • 1. Adults aged at least18 years (no upper age limit)
  • 2. Individuals diagnosed with non-metastatic breast, prostate or colorectal cancer in 2012-2015
  • 3. Individuals not receiving active anti-cancer treatment (except for those oral anti-cancer treatments taken at home who can be included)
  • 4. Individuals who are able to understand spoken and written English
  • Previous inclusion criteria:
  • ASCOT patient survey:
  • All individuals diagnosed with breast, prostate or colorectal cancer in 2012 or 2013 at an NHS trust in London or Essex.
  • ASCOT pilot trial:
  • 1. Adults aged at least18 years (no upper age limit)
  • 2. Individuals diagnosed with non-metastatic breast, prostate or colorectal cancer in 2012 or 2013
  • 3. Individuals not receiving active anti-cancer treatment (except for those oral anti-cancer treatments taken at home who can be included)
  • 4. Individuals who are able to understand spoken and written English

排除标准

  • ASCOT pilot trial:
  • 1. Individuals with metastatic disease
  • 2. Individuals on active anti-cancer treatment requiring hospital admission
  • 3. Individuals with severe cognitive impairment

研究者

发起方
niversity College London Joint Research Office

相似试验